Paydaş Analizi

O tema central dessa tese de doutorado é a importância do uso da eletroneuromiografia para a avaliação da neuropatia hansênica, uma complicação muito prevalente da infecção.

O que já se sabia sobre o assunto é que o dano neural é amplamente avaliado por exames clínicos, como o teste muscular voluntário e de monofilamentos, que produzem um diagnóstico tardio da neuropatia. Já sabíamos também que o tratamento com corticosteroides é mais efetivo quando aplicado no início da lesão neural. Compreendemos que a eletroneuromiografia consegue realizar um diagnóstico precoce do dano neural, pois detecta alterações subclínicas imperceptíveis ao exame físico. Portanto, para um tratamento mais efetivo da neuropatia é preciso que o diagnóstico do dano neural seja realizado o mais precoce possível. Descobrimos que um homem entre 41 e 60 anos apresentando formigamento e espessamento neural são características que aumentam a chance de desenvolver a neuropatia hansênica. Sendo assim, para um diagnóstico mais precoce da neuropatia hansênica se deveria levar em consideração o exame de eletroneuromiografia e os fatores clínicos mais associados.

Desse modo, seria possível aumentar a prevenção de incapacidade física e deformidades e consequentemente atingiríamos a meta da Organização Mundial de Saúde de reduzir a incidência de pacientes com incapacidade grau 2 até 2015.

REFERÊNCIAS

ANDERSON, A. M.; CROFT, R. P. Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh. Lepr Rev, v. 70, n. 3, p. 305-13, Sep 1999.

ARAD, Y. et al. Beyond the monofilament for the insensate diabetic foot: a systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetes. Diabetes Care, v. 34, n. 4, p. 1041-6, Apr 2011.

BATHALA, L. et al. Ulnar neuropathy in hansen disease: clinical, high-resolution ultrasound and electrophysiologic correlations. J Clin Neurophysiol, v. 29, n. 2, p. 190- 3, Apr 2012.

BOKU, N. et al. Impacts of the diagnosis of leprosy and of visible impairments amongst people affected by leprosy in Cebu, the Philippines. Lepr Rev, v. 81, n. 2, p. 111-20, Jun 2010.

BRANDSMA, J. W. et al. Intertester reliability of manual muscle strength testing in leprosy patients. Lepr Rev, v. 69, n. 3, p. 257-66, Sep 1998.

BRASIL. Guia para o Controle da Hanseníase. 3. Brasília: Minitério da Saúde, 2002.

BRASIL. Portaria 3.125. Secretaria de Vigilância em Saúde. Brasília: Ministério da Saúde 2010.

BRASIL. Plano integrado de ações estratégicas de eliminação da hanseníase,

filariose, esquistossomose e oncocercose como problema de saúde pública, tracoma como causa de cegueira e controle das geohelmintíases : plano de ação 2011-2015. Brasília: Ministério da Saúde 2012.

BRITTON, W. J.; LOCKWOOD, D. N. Leprosy. Lancet, v. 363, n. 9416, p. 1209-19, Apr 10 2004.

BROWNE, S. G. The history of leprosy. Edinburgh: Longman Group Limited, 1985.

CARDOSO, M. et al. Late onset neuropathy in leprosy patients released from treatment: not all due to reactions? Lepr Rev, v. 84, n. 2, p. 128-35, Jun 2013.

CHEN, S. et al. Inter-observer reliability in assessment of sensation of skin lesion and enlargement of peripheral nerves in leprosy patients. Lepr Rev, v. 77, n. 4, p. 371-6, Dec 2006.

CHOPRA, J. S. et al. Clinical, electrophysiological and teased fibre study of peripheral nerves in leprosy. Indian J Med Res, v. 77, p. 713-21, May 1983.

CRAMPIN, A. C.; GLYNN, J. R.; FINE, P. E. What has Karonga taught us?

Tuberculosis studied over three decades. Int J Tuberc Lung Dis, v. 13, n. 2, p. 153-64, Feb 2009.

CROFT, R. P. et al. Incidence rates of acute nerve function impairment in leprosy: a prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study). Lepr Rev, v. 71, n. 1, p. 18-33, Mar 2000.

CROFT, R. P. et al. A clinical prediction rule for nerve function impairment in leprosy patients-revisited after 5 years of follow-up. Lepr Rev, v. 74, n. 1, p. 35-41, Mar 2003.

CUNHA, F. M. B. et al. Pure neural leprosy: diagnostic value of the polymerase chain reaction. Muscle Nerve, v. 33, n. 3, p. 409-14, Mar 2006.

DHAVALIKAR, M.; NARKEESH, A.; GUPTA, N. Effect of Skin Temperature on Nerve Conduction Velocity and Reliability of Temperature Correction Formula in Indian Females. J Exerc Sci Physiother, v. 5, n. 1, p. 24-29, 2009.

DORFMAN, L. J.; ROBINSON, L. R. AAEM minimonograph #47: normative data in electrodiagnostic medicine. Muscle Nerve, v. 20, n. 1, p. 4-14, Jan 1997.

EICHELMANN, K. et al. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr, v. 104, n. 7, p. 554-63, Sep 2013.

ELIAS JR., J. et al. Role of ulnar nerve sonography in leprosy neuropathy with electrophysiologic correlation. J Ultrasound Med, v. 28, n. 9, p. 1201-9, Sep 2009.

FERREIRA, M. et al. A demanda de um centro de referência nacional para hanseníase no Nordeste Brasileiro: por que o excesso de pacientes? Cad Saúde Colet., v. 16, n. 2, p. 14, 2008.

FOSS, N. T. Aspectos imunológicos da hanseníase. Medicina (Ribeirão Preto), v. 30, p. 335-339, 1997.

FRADE, M. A. et al. New sonographic measures of peripheral nerves: a tool for the diagnosis of peripheral nerve involvement in leprosy. Mem Inst Oswaldo Cruz, v. 108, n. 3, May 2013.

GALVAO, P. R. et al. An evaluation of the Sinan health information system as used by the Hansen's disease control programme, Pernambuco State, Brazil. Lepr Rev, v. 79, n. 2, p. 171-82, Jun 2008.

GARBINO, J. A. et al. Primary neural leprosy: systematic review. Arq Neuropsiquiatr, v. 71, p. 397-404, 2013.

GARBINO, J. A. et al. Neurophysiological patterns of ulnar nerve neuropathy in leprosy reactions. Lepr Rev, v. 81, n. 3, p. 206-15, Sep 2010.

GOMES, C. C. D. et al. Perfil clínico-epidemiológico dos pacientes diagnosticados com hanseníase em um centro de referência na região nordeste do Brasil. An Bras Dermatol, v. 80, p. S283-S288, 2005.

HAN, X. Y.; SILVA, F. J. On the age of leprosy. PLoS Negl Trop Dis, v. 8, n. 2, p. e2544, Feb 2014.

HUSAIN, S.; MALAVIYA, G. N. Early nerve damage in leprosy: an

electrophysiological study of ulnar and median nerves in patients with and without clinical neural deficits. Neurol India, v. 55, n. 1, p. 22-6, Jan-Mar 2007.

IGNOTTI, E.; PAULA, R. C. Situação Epidemiológica da Hanseníase no Brasil: análise de indicadores selecionados no período de 2001 a 2010. In: BRASIL (Ed.). Saúde Brasil 2010: uma análise da situação de saúde e de evidências selecionadas de impacto de ações de vigilância em saúde. Brasília: Ministério da Saúde. Secretaria de Vigilância em Saúde (Org.). , v.1, 2011. p.185-202.

ILA, T. Report of the International Leprosy Association Technical Forum. Paris, France, 25-28 February 2002. Indian J Lepr, v. 74 Suppl, p. 1-93, 2002.

IMBIRIBA, E. N. et al. Social inequality, urban growth and leprosy in Manaus: a spatial approach. Rev Saúde Públ., v. 43, n. 4, p. 656-65, Aug 2009.

JAIN, S. et al. High-resolution sonography: a new technique to detect nerve damage in leprosy. PLoS Negl Trop Dis, v. 3, n. 8, p. e498, 2009.

JARDIM, M. R. et al. Clinical, electroneuromyographic and morphological studies of pure neural leprosy in a Brazilian referral centre. Lepr Rev, v. 75, n. 3, p. 242-53, Sep 2004.

JENA, S.; MISHRA, S.; MOHANTY, G. Silent neuropathy in leprosy. Indian J Dermatol Venereol Leprol, v. 68, n. 2, p. 84-5, Mar-Apr 2002.

KAHAWITA, I. P.; WALKER, S. L.; LOCKWOOD, D. N. J. Leprosy type 1 reactions and erythema nodosum leprosum. An Bras Dermatol, v. 83, p. 75-82, 2008.

KAR, B. R.; JOB, C. K. Visible deformity in childhood leprosy--a 10-year study. Int J Lepr Other Mycobact Dis, v. 73, n. 4, p. 243-8, Dec 2005.

KAR, S. et al. Nerve damage in leprosy: An electrophysiological evaluation of ulnar and median nerves in patients with clinical neural deficits: A pilot study. Indian Dermatol Online J, v. 4, n. 2, p. 97-101, Apr 2013.

KHAMBATI, F. A. et al. Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting peripheral nerve abnormality, using nerve conduction studies as gold standard; a study in 357 patients. Lepr Rev, v. 80, n. 1, p. 34-50, Mar 2009.

KIM, W. et al. Comparison of sarcopenic status between elderly leprosy survivors and general population. Arch Gerontol Geriatr, v. 58, n. 1, p. 134-9, Jan-Feb 2014.

LAGUARDIA, J. et al. Sistema de Informação de Agravos de Notificação (Sinan): desafios no desenvolvimento de um sistema de informação em saúde. Epidemiol. Serv. Saude, v. 13, n. 3, p. 135-147, 2004.

LANCET, N. Leprosy as a neurological disease. Lancet Neurol, v. 8, n. 3, p. 217, Mar 2009.

LANDIS, J. R.; KOCH, G. G. The measurement of observer agreement for categorical data. Biometrics, v. 33, n. 1, p. 159-74, Mar 1977.

LASRY-LEVY, E. et al. Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in Mumbai. PLoS Negl Trop Dis, v. 5, n. 3, p. e981, 2011.

LEHMAN, L. et al. Avaliação Neurológica Simplificada. Belo Horizonte: ALM International, 1997.

LEITE, V. M.; LIMA, J. W.; GONCALVES, S. Silent neuropathy in patients with leprosy in the city of Fortaleza, Ceara State, Brazil. Cad. Saúde Pública, v. 27, n. 4, p. 659-65, Apr 2011.

LEWIS, S. Reproducibility of sensory testing and voluntary muscle testing in evaluating the treatment of acute neuritis in leprosy patients. Lepr Rev, v. 54, n. 1, p. 23-30, Mar 1983.

LIMA, P. O. et al. Reproducibility of the pressure biofeedback unit in measuring transversus abdominis muscle activity in patients with chronic nonspecific low back pain. J Bodyw Mov Ther, v. 16, n. 2, p. 251-7, Apr 2012.

LOCKWOOD, D. N.; SARNO, E.; SMITH, W. C. Classifying leprosy patients-- searching for the perfect solution? Lepr Rev, v. 78, n. 4, p. 317-20, Dec 2007.

LOCKWOOD, D. N.; SAUNDERSON, P. R. Nerve damage in leprosy: a continuing challenge to scientists, clinicians and service providers. Int Health, v. 4, n. 2, p. 77-85, Jun 2012.

MACDERMID, J. C.; KRAMER, J. F.; ROTH, J. H. Decision making in detecting abnormal Semmes-Weinstein monofilament thresholds in carpal tunnel syndrome. J Hand Ther, v. 7, n. 3, p. 158-62, Jul-Sep 1994.

MASTRANGELO, G. et al. Leprosy reactions: the effect of gender and household contacts. Mem Inst Oswaldo Cruz, v. 106, n. 1, p. 92-6, Feb 2011.

MCKNIGHT, J. et al. Reference values for nerve function assessments among a study population in northern India - III: sensory and motor nerve conduction. Neurology Asia, v. 15, n. 1, p. 39-54, 2010.

MEIMA, A.; VAN VEEN, N. H.; RICHARDUS, J. H. Future prevalence of WHO grade 2 impairment in relation to incidence trends in leprosy: an exploration. Trop Med Int Health, v. 13, n. 2, p. 241-6, Feb 2008.

MENDONÇA, V. A. et al. Imunologia da hanseníase. An Bras Dermatol, v. 83, p. 343-350, 2008.

MISRA, U. K.; KALITA, J. Clinical neurophysiology. 1. New Delhi: Elsevier, 2006.

MISRA, U. K.; KALITA, J.; NAIR, P. P. Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol, v. 11, n. 2, p. 89-97, Apr 2008.

MONOT, M. et al. On the origin of leprosy. Science, v. 308, n. 5724, p. 1040-2, May 13 2005.

MONTENEGRO, A. C. et al. Spatial analysis of the distribution of leprosy in the State of Ceara, Northeast Brazil. Mem Inst Oswaldo Cruz, v. 99, n. 7, p. 683-6, Nov 2004.

MOSCHIONI, C. et al. Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy. Rev Soc Bras Med Trop, v. 43, n. 1, p. 19-22, Jan-Feb 2010.

MURTHY, P. K. Clinical manifestations, diagnosis and classification of leprosy. J Indian Med Assoc, v. 102, n. 12, p. 678-9, Dec 2004.

NARDI, S. M. T.; PASCHOAL, V. D. A.; ZANETTA, D. M. T. Frequência de avaliações e seu impacto na prevenção das incapacidades físicas durante o tratamento dos pacientes com hanseníase. . Hansen Int v. 30, p. 157-66, 2005.

NASCIMENTO, O. J. M. Leprosy neuropathy: clinical presentations. Arq Neuropsiquiatr, v. 71, p. 661-666, 2013.

NORMAN, G.; JOSEPH, G.; RICHARD, J. Validity of the WHO operational classification and value of other clinical signs in the classification of leprosy. Int J Lepr Other Mycobact Dis, v. 72, n. 3, p. 278-83, Sep 2004.

OLIVEIRA, D. T. et al. Neurological disability in leprosy: incidence and gender association in Sergipe, Brazil. Geospat Health, v. 6, n. 3, p. S125-9, Sep 2012.

OLIVEIRA, D. T. D. et al. Clinical variables associated with leprosy reactions and persistence of physical impairment. Rev Soc Bras Med Trop, v. 46, p. 600-604, 2013.

OPROMOLLA, P. A.; MARTELLI, A. C. C. A terminologia relativa à hanseníase. An Bras Dermatol, v. 80, p. 293-294, 2005.

PANDHI, D.; CHHABRA, N. New insights in the pathogenesis of type 1 and type 2 lepra reaction. Indian J Dermatol Venereol Leprol, v. 79, n. 6, p. 739-49, Nov-Dec 2013.

PENNA, G. O. et al. A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design. Mem Inst Oswaldo Cruz, v. 107 Suppl 1, p. 22-7, Dec 2012.

PENNA, M. L. et al. Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients. Lepr Rev, v. 83, n. 3, p. 308-19, Sep 2012.

PENNA, M. L.; OLIVEIRA, M. L.; PENNA, G. O. The epidemiological behaviour of leprosy in Brazil. Lepr Rev, v. 80, n. 3, p. 332-44, Sep 2009.

PENNA, M. L.; PENNA, G. O. Trend of case detection and leprosy elimination in Brazil. Trop Med Int Health, v. 12, n. 5, p. 647-50, May 2007.

RABELLO, F. The indeterminate group of hanseniasis, and its basic connotation: the polar concept. An evaluation and a refutation of the so-called “spectral” approach. Hansenol int, v. 1, p. 111-119, 1976.

RAMBUKKANA, A. How does Mycobacterium leprae target the peripheral nervous system? Trends Microbiol, v. 8, n. 1, p. 23-8, Jan 2000.

REJA, A. H. et al. Use of fine needle aspirate from peripheral nerves of pure-neural leprosy for cytology and PCR to confirm the diagnosis: a pilot study. Indian J Dermatol Venereol Leprol, v. 79, n. 6, p. 789-94, Nov-Dec 2013.

RICHARD, J. et al. Recent trends in new case detection rates in leprosy by age and sex in Gudiyatham Taluk, Tamil Nadu, India. Indian J Lepr, v. 82, n. 3, p. 131-5, Jul-Sep 2010.

RICHARDUS, J. H.; HABBEMA, J. D. The impact of leprosy control on the

transmission of M. leprae: is elimination being attained? Lepr Rev, v. 78, n. 4, p. 330-7, Dec 2007.

RICHARDUS, J. H. et al. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up. Int J Epidemiol, v. 33, n. 2, p. 337-43, Apr 2004.

RIDLEY, D. S. [The pathogenesis and classification of polar tuberculoid leprosy]. Lepr Rev, v. 53, n. 1, p. 19-26, Mar 1982.

RIDLEY, D. S.; JOPLING, W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis, v. 34, n. 3, p. 255-73, Jul-Sep 1966.

ROBERTS, A. E. et al. Ensuring inter-tester reliability of voluntary muscle and

monofilament sensory testing in the INFIR Cohort Study. Lepr Rev, v. 78, n. 2, p. 122- 30, Jun 2007.

RODRIGUES, L. C.; LOCKWOOD, D. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis, v. 11, n. 6, p. 464-70, Jun 2011.

ROTHMAN, K.; GREENLAND, S.; LASH, T. Modern Epidemiology. 3rd. Philadelphia: Lippincott Williamns & Wilkins, 2008.

SAMANT, G. et al. Clinical and electrophysiological evaluation of nerve function impairment following cessation of multidrug therapy in leprosy. Lepr Rev, v. 70, n. 1, p. 10-20, Mar 1999.

SAUNDERSON, P. The epidemiology of reactions and nerve damage. Lepr Rev, v. 71 Suppl, p. S106-10, Dec 2000.

SAUNDERSON, P. et al. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev, v. 71, n. 3, p. 285-308, Sep 2000.

SCHREUDER, P. A. The occurrence of reactions and impairments in leprosy:

experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments. Int J Lepr Other Mycobact Dis, v. 66, n. 2, p. 170-81, Jun 1998.

SEILER, D. K.; WILTON, J.; DELLON, A. L. Detection of neuropathy due to

Mycobacterium leprae using noninvasive neurosensory testing of susceptible peripheral nerves. Ann Plast Surg, v. 55, n. 6, p. 633-7, Dec 2005.

SKACEL, M. et al. The diagnosis of leprosy among patients with symptoms of peripheral neuropathy without cutaneous lesions: a follow-up study. Arq Neuropsiquiatr, v. 58, n. 3B, p. 800-7, Sep 2000.

SLATER, R. A. et al. Interpreting the results of the Semmes-Weinstein monofilament test: accounting for false-positive answers in the international consensus on the diabetic foot protocol by a new model. Diabetes Metab Res Rev, v. 30, n. 1, p. 77-80, Jan 2014.

SLIM, F. J. et al. Effects of impairments on activities and participation in people affected by leprosy in The Netherlands. J Rehabil Med, v. 42, n. 6, p. 536-43, Jun 2010.

SMITH, W. C. et al. Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1). BMJ, v. 328, n. 7454, p. 1459, Jun 19 2004.

SMITH, W. C. et al. Predicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study. PLoS Negl Trop Dis, v. 3, n. 8, p. e500, 2009.

SMITH, W. C.; SAUNDERSON, P. Leprosy. Clin Evid (Online), v. 2010, 2010.

SOYSAL, A. et al. Electrophysiological evaluation of peripheral and autonomic involvement in leprosy. Can J Neurol Sci, v. 31, n. 3, p. 357-362, 2004.

SURESH, M. et al. Voluntary muscle testing and dynamometry in diagnosis of motor impairment in leprosy: a comparative study within the INFIR Cohort Study. Lepr Rev, v. 79, n. 3, p. 277-94, Sep 2008.

TALHARI, S.; NEVES, R. G. Dermatologia tropical – Hanseníase. 1. Manaus: Gráfica Tropical, 1997.

UPLEKAR, M. W.; ANTIA, N. H. Clinical and histopathological observations on pure neuritic leprosy. Indian J Lepr, v. 58, n. 4, p. 513-21, Oct-Dec 1986.

VAN BRAKEL, W. H. Peripheral neuropathy in leprosy and its consequences. Lepr Rev, v. 71 Suppl, p. S146-53, Dec 2000.

VAN BRAKEL, W. H. et al. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). Lepr Rev, v. 74, n. 4, p. 300-10, Dec 2003.

VAN BRAKEL, W. H.; KHAWAS, I. B. Silent neuropathy in leprosy: an epidemiological description. Lepr Rev, v. 65, n. 4, p. 350-60, Dec 1994.

VAN BRAKEL, W. H. et al. Intra- and inter-tester reliability of sensibility testing in leprosy. Int J Lepr Other Mycobact Dis, v. 64, n. 3, p. 287-98, Sep 1996.

VAN BRAKEL, W. H. et al. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline. Lepr Rev, v. 76, n. 4, p. 277-95, Dec 2005.

VAN BRAKEL, W. H. et al. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. Lepr Rev, v. 76, n. 1, p. 14-34, Mar 2005.

VAN BRAKEL, W. H. et al. Early diagnosis of neuropathy in leprosy--comparing diagnostic tests in a large prospective study (the INFIR cohort study). PLoS Negl Trop Dis, v. 2, n. 4, p. e212, 2008.

VAN BRAKEL, W. H. et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Glob Health Action, v. 5, 2012.

VILLARROEL, M. F. et al. Comparative study of the cutaneous sensation of leprosy- suspected lesions using Semmes-Weinstein monofilaments and quantitative thermal testing. Lepr Rev, v. 78, n. 2, p. 102-9, Jun 2007.

VISSER, L. H. et al. Morphological changes of the epineurium in leprosy: a new finding detected by high-resolution sonography. Muscle Nerve, v. 46, n. 1, p. 38-41, Jul 2012.

VITAL, R. T. et al. Progression of leprosy neuropathy: a case series study. Brain Behav, v. 2, n. 3, p. 249-55, May 2012.

WAGENAAR, I. et al. Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols. BMC Neurol, v. 12, p. 159, 2012.

WHO. Chemotherapy of leprosy control programmes. 675. Geneva: World Health Organization, 1982.

WHO. Leprosy Resolution. Forty-fourth World Health Assembly, 1991. 44-49.

WHO. Global leprosy situation. Weekly epidemiological record. 30 august 2013. World Health Organization, 2013. 365-380.